0001209191-21-056459.txt : 20210916 0001209191-21-056459.hdr.sgml : 20210916 20210916181601 ACCESSION NUMBER: 0001209191-21-056459 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210914 FILED AS OF DATE: 20210916 DATE AS OF CHANGE: 20210916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brinkley Ruth Williams CENTRAL INDEX KEY: 0001344381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36257 FILM NUMBER: 211258833 MAIL ADDRESS: STREET 1: C/O TRAVERE THERAPEUTICS, INC. STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER NAME: FORMER CONFORMED NAME: Brinkley Ruth W DATE OF NAME CHANGE: 20051114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Travere Therapeutics, Inc. CENTRAL INDEX KEY: 0001438533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262383102 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DR STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 888-969-7879 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DR STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Retrophin, Inc. DATE OF NAME CHANGE: 20130220 FORMER COMPANY: FORMER CONFORMED NAME: Desert Gateway, Inc. DATE OF NAME CHANGE: 20080625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-14 0 0001438533 Travere Therapeutics, Inc. TVTX 0001344381 Brinkley Ruth Williams C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2021-09-14 4 A 0 5250 0.00 A 5250 D Stock Option (Right to Buy) 23.61 2021-09-14 4 A 0 15750 0.00 A 2031-09-13 Common Stock 15750 15750 D One-third of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 24 equal monthly installments thereafter. /s/ Elizabeth E. Reed, Attorney-in-Fact 2021-09-16